HHS said the investment will boost test production in Baldwin, Hudson, Somerset and Menomonie in Wisconsin; Gulliford in Maine; and Anaheim and San Diego in California. The money should increase production capacity to 13 million COVID-19 tests per month by January 2022, the departments said.
“Hologic’s platform is in high demand, and with this investment we will be able to improve the supply to laboratories across the country, in addition to scaling up employment in Hologic supplier facilities,” said HHS Assistant Secretary for Health Brett Giroir, MD.
Hologic said it has 2,000 test processing machines in labs around the world, including in all 50 states.
Read the full news release here.
More articles on supply chain:
CDC seeks to create centralized reporting system for COVID-19 test results
Abbott sues former exec, claims he shared trade secrets
FDA warns of potential for false positives in coronavirus antigen tests
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
